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Abstract  
Variation in both nuclear shape and size (“pleomorphism”), coupled with changes in chromatin 
amount and distribution, remains the basic criteria for microscopy in a cytologic diagnosis of 
cancer. The biological determinants of nuclear shape irregularities are not clarifi ed, so, rather than 
on the genesis of nuclear irregularities, we here focus our attention on a descriptive analysis of 
nuclear pleomorphism.  
We keep in mind that evaluation of nuclear shape as currently practiced in routine preparations is 
improper because it is indirectly based on the distribution of DNA as revealed by the affi nity for 
basic dyes. Therefore, over the last years we have been using as criteria morphological features of 
nuclei of thyroid and breast carcinomas as determined by immunofl uorescence, in situ 
hybridization, and 3D reconstruction. We have translated this approach to routine diagnostic 
pathology on tissue sections by employing immunoperoxidase staining for emerin. Direct detection 
of nuclear envelope irregularities by tagging nuclear membrane proteins such as lamin B and 
emerin has resulted in a more objective defi nition of the shape of the nucleus. In this review we 
discuss in detail methodological issues as well as diagnostic and prognostic implications provided 
by decoration/staining of the nuclear envelope in both thyroid and breast cancer, thus 
demonstrating how much it matters “to be in the right shape” when dealing with pathological 
diagnosis of cancer. 
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Abbreviations 
FISH Fluorescence in situ hybridization 
H&E Hematoxylin and eosin 
NE Nuclear envelope 
PTC Papillary thyroid carcinoma 
PDC Poorly differentiated carcinoma 
NEP Nuclear envelope pleomorphism 
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Introduction 
Irregularity of nuclear shape and an increased nuclear-cytoplasmic ratio (also called karyoplasmic 
ratio) characterize most, though not all, neoplastic conditions. In fact, we can roughly consider, as 
far as nuclear shape in cancer is concerned, three types of events. In some tumors, nuclei are 
roundish, with a smooth nuclear membrane not dissimilar from the corresponding normal 
epithelium. However, in the vast majority of cancers most nuclei are pleomorphic, as defi ned by 
the presence of irregularities in both nuclear shape and size coupled with changes in chromatin 
amount and distribution within the nucleus [ 1 ]. Such features remain the basic microscopy criteria 
for a cytologic diagnosis of cancer: indeed, indentations, undulations, and folds of the nuclear 
membrane, as originally reported by ultrastructural observations [ 2 ], occur early in neoplastic 
processes [ 3 ]. 
Finally, in some types of cancer, and notably in thyroid cancer, nuclear shape irregularity presents 
a typical and reproducible pattern, acquiring clear diagnostic significance. Typically, papillary 
thyroid carcinoma (PTC) is characterized by the presence of indentations, grooves (the so-called 
coffee-bean nuclei), pseudo- inclusions (or “Orphan-Annie-eyed” nuclei), and nuclear clearing. 
These characteristics derive from fi nely dispersed chromatin or deep and complex cytoplasmic 
longitudinal invaginations into the double-membrane nuclear envelope (NE), as demonstrated by 
electron microscopy [ 4 – 7 ]. The presence of these features is the only clue to the diagnosis of 
PTC, which alone represents almost 80 % of all thyroid carcinomas [ 8 ]. 
The Nuclear Envelope and Rationale for Its Use in Pathology Light microscopy appreciation of 
nuclear pleomorphism in cytopathology and histopathology is indirect, as it is currently based on 
staining of nucleic acids with basic dyes such as hematoxylin. Since peripheral chromatin is bound 
to the nuclear membrane, this provides crude evidence of nuclear shape. However, a method to 
decorate the NE could provide direct detection of the NE and its components. 
Indeed, by highlighting NE-associated proteins we could provide a more objective and direct 
appreciation of nuclear shape and defi nitively reconstruct nuclear shape based on the distribution 
of NE proteins [ 1 ]. 
Detection, appreciation, and rendering of nuclear shape are, for intrinsic reasons, different in 
cytopathology and in histopathology. In fact, while in the cytological approach whole nuclei are 
available for investigations, in histological sections only nuclear segments are available, which 
makes images partial and seldom conclusive. 
Moreover, in diagnostic cytology, the preservation of nuclear shape is heavily infl uenced by the 
technical procedure for preparations, since in liquid cytology, the shape of the nucleus is fully 
preserved. By contrast, smearing followed by cell drying is bound to produce a collapse of the 
nuclear shape leading to misdiagnosis. 
With these caveats in mind, the following approaches have been followed by our group: A. Tagging 
of components of the nuclear membrane by immunofl uorescence and immunoperoxidase staining 
(Figs. 1 , 2 , and 3 ) B. Immunofl uorescence decoration of the nuclear membrane, associated with 
gene labeling by fl uorescence in situ hybridization (FISH) (Fig. 4 ) C. Confocal microscopy and 
image capture, followed by 3D reconstruction using specifi c software (e.g. Amira 3D Analysis 
Software for Life Sciences— http://www.vsg3d.com/ ) (Figs. 4 , 5 , and 6 ) D. Image analysis using 
specifi c softwares (e.g. Image-Pro Plus, MediaCybernetics, http://www.mediacy.com , which is an 
image analysis software package for fl uorescence imaging and for recording sequential images). 
Following these procedures, we have been able to trace the distribution of the NE with immunofl 
uorescence and immunoperoxidase procedures by using antibodies targeting lamin B and another 
NE marker, namely, emerin [ 9 ] (approaches A, B). 
These two proteins label different structural components, since lamin B is located in the 
proteinaceous layer at the interface between the chromatin and the membrane, while emerin is a 
transmembrane protein of the inner nuclear membrane [ 9 ]. We also obtained a proper 3D 
reconstruction of the nuclear shape (approaches B, C). 
Confocal microscopy analysis allows the creation of a stack of images along the z-axis that can be 
uploaded into dedicated software for advanced 3D visualization and volume modeling. The nuclear 
outline is obtained after segmentation of sequential images of nuclear sections [ 10 ]. The 
segmented areas are then employed to generate 3D polygonal surface models using macros in the 
dedicated software (approaches A, B, C). An alternative procedure to confocal microscopy for 
generating sharp images from tissue specimens is provided by deconvolution technology 
(approach D). Briefl y, immunofl uorescent preparations are examined typically with a wide-fi eld fl 
uorescence microscope, equipped with either a motorized stage or a piezo focus lens positioner, a 
camera, and a dedicated software that allows 3D image stacks to be recorded. Subsequent 
deconvolution of the image stacks improves the clarity of images by applying an algorithm that 
uses pixel information in the adjacent sections to remove out-of-focus light [ 11 , 12 ]. With confocal 
microscopy a single nucleus can be observed at different and sequential cutting planes, and a 3D 
reconstruction can be 
obtained by adding each 
section to build up the 
entire nuclear volume. 
Similarly, after removal 
of the out-offocus light by 
deconvolution, the 
individual sections can 
be reconstructed to obtain 
3D models. 
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 Fig. 1 How emerin staining in both immunofl uorescence and immunoperoxidase highlights nuclear shape in a spectrum 
of thyroid lesions. Panels ( a – c ) are a follicular adenoma stained in various ways. The presence of round and regular 
nuclei is evident. Parallel sections were stained with ( a ) hematoxylin and eosin (H&E), ( b ) immunofl uorescence for 
emerin, and ( c ) immunoperoxidase for emerin. Panels ( d – h ) are an example of papillary thyroid carcinoma showing 
NE irregularities. ( d ) An H&Estained section of a thyroid proliferation with irregular nuclei and scarce pseudo-inclusions 
( arrow ). ( e ) The irregularities become extremely evident with immunofl uorescence for emerin. ( f – h ) Similarly 
immunoperoxidase staining for emerin reveals the presence of several pseudo-inclusions by marking nuclear shape and 
highlighting its foldings ( arrows in e – h : evident and widespread nuclear pseudoinclusions). Panels ( i – k ) are a case 
of poorly differentiated carcinoma. ( i ) H&E staining reveals nuclei to look quite regular with only scarce irregularities of 
the nuclear contours. ( j ) Immunofl uorescence staining for emerin reveals nuclei that can look quite regular (as in 
follicular lesions). ( k ) However, in some cells this staining reveals the so-called star-shaped or raisin-like features 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Emerin staining in cytological specimens of papillary thyroid carcinoma. ( a – d ) Cases of papillary thyroid 
carcinoma (PTC) in alcohol-fi xed smears, ( e ) with Thin Prep, and panels ( f – h ) are cell blocks obtained from fi ne 
needle aspirations on thyroid nodules. In smears ( a , c ) cells are stained with hematoxylin and eosin (H&E), while ( b , 
d) are the same fi elds and nuclei stained with immunoperoxidase for emerin. Direct comparison of the same fi elds 
reveals the superior ability of emerin staining to highlight diagnostic nuclear features, such as nuclear pseudo-inclusions 
(arrows in a , b ), even of very small size ( arrow in d ), grooves, and crescent-like fi gures. ( e ) On Thin Prep 
preparations, pseudo-inclusions are evident. ( f – h ) The emerin-stained sections obtained from cell block highlight other 
features typical of PTC, such as the garland-like appearance ( f ) and deep irregularities of nuclear shape ( g , h ) 
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 Fig. 3 Micrographs depicting different scenarios in the evaluation of nuclear pleomorphism in breast cancer pathology. 
Ductal carcinoma in situ (DCIS) of low nuclear grade ( a , b ) shows a regular lining of the nuclear envelope by immunofl 
uorescence for emerin ( b ). ( c , d ) Immunofl uorescence for emerin best shows fi ne irregularities of the nuclei in ductal 
carcinoma in situ of high nuclear grade. ( e , f ) Finally, an example of infi ltrating ductal carcinoma (IDC) of low 
histological grade shows high-grade nuclear envelope pleomorphism (NEP), as best highlighted by immunofl uorescence 
for emerin 
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Fig. 4 3D reconstruction of nuclei with visualization of HER2 gene. ( a , b ) Immunofl uorescence for lamin B ( green ) is 
performed together with fluorescence in situ hybridization (FISH) for the HER2 gene ( red signals) in BT-474 cells ( 
HER2 amplifi ed, as exemplifi ed by the gene clusters). ( c – f ) 3D reconstruction of these nuclei shows the relationship 
between HER2 gene clusters and nuclear envelope 
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Fig. 5 3D reconstruction of PTC nuclei. Panels ( a – d ) are images obtained from sequential cutting planes of a single 
papillary thyroid carcinoma (PTC) nucleus, while images from ( e – g ) are different perspectives of a 3D reconstruction 
of another example of PTC nucleus. Immunofl uorescence for emerin was performed on sequential sections of nuclei 
from PTC cell lines, and a 3D reconstruction was obtained using software Amira (Amira 3D Analysis Software for Life 
Sciences— http://www.vsg3d.com). The models of nuclear shape here shown revealed the presence of irregularities of 
the nuclear membrane with foldings and invaginations, which corresponds to the so-called coffee bean (or grooves) on 
traditional H&E-stained nuclei 
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Fig. 6 3D reconstruction of breast cancer nuclei. Panels ( a – d ) and ( e – h ) are images obtained from sequential 
cutting planes of two different nuclei of breast cancer. Immunofl uorescence for lamin B was performed on sequential 
sections of nuclei from breast cancer cells (BT-474). The software Amira (Amira 3D Analysis Software for Life 
Sciences—http://www.vsg3d.com) was used to obtain a 3D reconstruction. The 3D models highlight irregularities of 
nuclear contour and several intranuclear tubules 
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Diagnostic and Clinical Impact of Nuclear Shape in PTC 
Over the years, we have focused our attention on nuclear pleomorphisms and alterations in shape 
(dysmorphisms) that occur in cancers and specifi cally in thyroid and breast carcinomas, two areas 
in which nuclear pleomorphism holds high biological signifi cance and great diagnostic and 
prognostic impact. In breast carcinoma the nuclear shape varies according to the histological 
subtype and grade, involving also a prognostic significance. In thyroid carcinomas the nuclear 
shape is instead paradigmatic and diagnostic of specific types of cancer. 
Nuclear Shape in PTC and PDC Versus Other Thyroid Pathologies 
A study conducted on cell lines derived from PTC and from follicular carcinomas, as well as on 
histological sections and cytological fi ne needle aspiration samples, showed an intense and 
diffuse staining for lamin B along the nuclear membrane irrespective of the tumor type [ 10 ]. 
Remarkable nuclear deformities, infolding, and “tubelike” invaginations were evident in the vast 
majority of PTC nuclei, and the typical intranuclear pseudoinclusions were also lined by lamin B. 
Moreover, PTC nuclei were larger and much more irregular than the corresponding control cases 
of follicular tumors (Fig. 1 ). The invaginations and indentations of PTC nuclei, as revealed by the 
sequential reconstructions obtained with the use of the confocal microscope, appeared to 
penetrate into the nucleus to a variable degree from a minimal fraction up to reach an entire 
penetration, which, as a consequence, acquires a “donut-like” configuration. Serial sections 
showed that “pouches” or “tunnels” that were seen in 3D reconstructions (Fig. 5 ) corresponded to 
the pseudo-inclusions typical of PTC nuclei and appeared to be always connected to the cell 
cytoplasm and lined by intact nuclear membrane. 
In control cases of follicular tumors, nuclei were smaller than in PTC, with a round or an oval shape 
and a regular and smooth contour. Confocal microscope and 3D-reconstruction images highlighted 
the presence of only slight and occasional deformities. It can be thus concluded that the typical 
irregularities of PTC nuclei may appear at the light microscopy level alternatively as grooves or 
pseudo-inclusions according to the viewpoint from which the cell is explored, but they are all facets 
of the same phenomenon of large-scale invaginations with reciprocal cytoplasm bulging. 
Moreover, the study with confocal microscopy and 3D reconstructions acquired diagnostic 
usefulness, since it opened the possibility to apply knowledge on nuclear shape and volume to the 
so-called grey area of thyroid pathology, which comprises follicular patterned lesions with optically 
clear nuclei but without clear-cut features of PTC. Irregularly shaped nuclei in fact can also be 
found in thyroiditis, hyperplastic lesions, goiter with degenerative changes, oxyphilic tumors or be 
the consequence of the fi ne needle aspiration procedure or the fi xation artefacts [ 13 ]. 
These benign lesions may have nuclear irregularities that mimic those of PTC: besides clear 
nuclei, occasional grooves can be appreciated and widespread alterations of nuclear contour are 
often present. What distinguishes these lesions from PTC is a combination of several factors, both 
histological (architecture, presence of vascular and/or capsular invasion) and cytological (extent, 
frequency, and intensity of nuclear irregularities, presence of nuclear pseudo-inclusions), but 
traditional staining may not be sufficient to fully appreciate these differences and distinction may be 
challenging. For this reason, the use of immunohistochemical staining to improve detection of 
nuclear shape might be of help in this differential diagnosis. 
In order to apply this method of nuclear stain to routine histological and cytological diagnosis, 
immunohistochemical staining with anti-emerin antibodies was evaluated [ 9 , 14 , 15 ]. Emerin is a 
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protein of the inner nuclear membrane which appears to interact with the lamina and chromatin; it 
is a serine-rich nuclear membrane protein involved in mediating membrane anchorage to the 
cytoskeleton [ 16 ]. Fischer et al. [ 17 ] demonstrated that its expression is not reduced or 
abolished in cytoplasmic pseudo-inclusions or grooves of PTC, but it simply conforms to nuclear 
irregularities and foldings. Thus, cases of PTC, follicular adenoma, follicular carcinoma, 
Hashimoto’s thyroiditis, goiter, Graves disease, and normal thyroid tissues were stained with anti-
emerin antibodies. 
In PTC, emerin staining allowed an easy identification of all previously described nuclear 
irregularities (invaginations, pseudo-inclusions, grooves, crescent-like nuclei, and deep-stellate 
nuclear shape) but also a peculiar pattern never described before, which is the presence of minute 
curls along the periphery of the nucleus, leading to a garland-like pattern (Figs. 1 and 2 ); 
moreover, when directly comparing the same nuclei stained with immunofl uorescence for emerin 
and subsequently restained with hematoxylin and eosin (H&E), it was evident that only some of the 
grooves seen with immunofluorescence were appreciable with H&E as well. For this reason, 
emerin staining was tested on cases of follicular variant of PTC (FVPTC). This controversial variant 
is in fact characterized by follicles lined by cells that lack the typical features of PTC: nuclei are 
dark, and irregularities of shape are often borderline. Grooves are scarce and pseudo-inclusions 
rare or totally absent [ 6 , 18 , 19 ]. For this reason, the diagnosis of FVPTC is traditionally affected 
by a high rate of inter-observer discordance, even among the so-called expert thyroid pathologists [ 
20 – 22 ]. The distinction between FVPTC on one side and benign lesions on the other (follicular 
adenoma, goiter, nodule in the context of thyroiditis) is based on the shape of the nucleus, 
presenting grooves and invaginations in the former while roundish in the latter. The differential 
diagnosis is important since it carries a profound therapeutic and prognostic impact, but it is 
sometimes difficult and problematic, because of improper preservation of the nuclear shape in 
histological sections. 
After emerin staining of cases of FVPTC, invaginations of the nuclear membrane were more 
evident than on H&E slides, and emerin tracing of the envelope allowed the recognition of some 
pseudo-inclusions that were “hidden” by the presence of dark nuclei in H&E preparations. 
Staining for emerin shows distinct and different patterns between PTC nuclei and other conditions, 
because it reveals more clearly nuclear irregularities in cases of PTC, while it confirms a regular 
nuclear profile in normal thyroid gland and other lesions (follicular lesions, goiter, thyroiditis). In 
fact, we have demonstrated that in thyroid lesions other than PTC, the vast majority of cells have 
smooth and round nuclei and only occasional cells may have irregularities of shape and 
invaginations similar to PTC nuclei [ 9 ]. Of note, such irregularities are only occasional and never 
reach the degree so typical and diagnostic of PTC. 
The diagnosis of poorly differentiated carcinoma (PDC) is based on a diagnostic algorithm 
involving the presence of a solid, trabecular, or insular histological pattern as well as of necrosis 
and increased rate of mitoses [ 23 ]. However, a role in the diagnosis is played by nuclei as well. In 
PDC, nuclei are small (if compared with PTC nuclei), round, and hyperchromatic and lack typical 
clear-cut features of PTC (pseudo-inclusions, grooves, crescent-like features). Nuclei in PDC 
appear as “convoluted” because of the presence of an irregular (“convoluted” or “raisin-like”) 
contour membrane. Only occasional grooves are observed, and no ground-glass appearance or 
pseudo-inclusions. By decorating/staining the NE with anti-emerin antibodies, PDC-convoluted or 
raisin-like nuclei showed humps and plicae, thus giving the appearance of a star-shaped structure 
(Fig. 1 ). 
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Thyroid Cytology 
Tracing the nuclear membrane by emerin decoration/staining could improve the preoperative 
cytological diagnosis of thyroid carcinomas. 
In particular, one of the main issues in thyroid cytopathology is the so-called indeterminate 
category, which includes cases where the lesion cannot be clearly defined as benign or malignant 
based on morphology alone; these cases are collectively grouped into the III and IV categories 
according to the Bethesda System for reporting Thyroid Cytopathology [ 24 ]. The categories III 
and IV (see Table 1a ) are considered a sort of “grey zone” of thyroid cytology, and several authors 
have discussed the issue of “indeterminate” thyroid fi ne needle aspiration diagnosis. Efforts to 
detect cytological features or ancillary procedures that could distinguish between benign and 
malignant follicular patterned lesions (in need of surgical removal) have been the subject of several 
studies, but none was found to have absolute value or reproducibility [ 25 – 31 ]. 
Our results showed that emerin correctly traced the nuclear membrane in all types of cytological 
specimens (smear, cell block, Thin Prep) (see Table 1b ). Smears and Thin Preps from cases with 
a defi nite cytological diagnosis of malignancy (category VI according to Bethesda System) [ 24 ] 
showed evident nuclear irregularities with foldings, grooves, and pseudo-inclusions. Comparison 
on the same nuclei of the H&E and immunoperoxidase slides (by recording H&E cytological 
images, demounting, and then restaining for emerin) (Fig. 2 ) clearly demonstrates the increased 
ability to defi ne the nuclear membrane and its irregularities. 
Table 1  
 
Categories for reporting thyroid cytopathology (Bethesda 
System)  (a) 
Categor Risk  of
I Nondiagnostic or Unsatisfactory 1-
II Benign 0-
3% 
III Atypia  of Undetermined Significance or Follicular  
Lesion of Unde-termined  Significance 
5-
15% 
IV Follicular  Neoplasm  or Suspicious  for a Follicular  
Neoplasm 
15-
30% 
V Suspicious  for Malignancy 60-
VI Malignant 97-
99% 
 
Cytology processing-tissue methods (b) 
Smear Specimens from FNA  are immediately  spread  thinly on a 
microscope  slide, air-dried  or alcohol- fixed and stained 
for examination. 
Thin Prep Specimens from FNA  are put in a special fluid collection system 
and the slides for cytologic examination are filtered out in one-
cell-thick layers on a slide. 
Cell-block Specimens   from   FNA   are   directly   fixed  in  alcohol,   
centrifugated,  paraffin-  embedded,  thus obtaining cell-blocks 
from which 3-5 μm sections can be cut. 
FNA = fi ne needle aspiration 
This approach proved particularly useful in the definition of unclear and problematic cases 
classified as III/IV categories: by highlighting and amplifying nuclear irregularities (e.g., 
invaginations, true inclusions, grooves), it helped in identifying, among all the indeterminate cases, 
the malignant lesions, which, after surgery, proved to be PTC or FVPTC. Those nuclear 
irregularities which were barely perceivable or borderline on H&E preparations proved instead 
more evident with emerin staining, and this helped in raising the suspicion of a malignant lesion. 
In conclusion, emerin staining proved a useful tool to correctly identify PTC nuclei and to 
discriminate FVPTC cases among lesions classified as III/IV categories according to the Bethesda 
System [ 24 ]. It can be performed on smears, even after H&E staining, thus allowing for the 
accurate and straightforward identification of nuclear changes characteristic of PTC even in fi ne 
needle aspiration samples with very scant cellularity (number of cells obtained by FNA). 
Diagnostic and Clinical Impact of Nuclear Shape in Breast Cancer 
In breast cancer diagnostic pathology it is well known that irregularities in nuclear shape as 
observed by H&E staining play a crucial role in the diagnosis of both in situ and infiltrative lesions. 
Indeed, in situ carcinomas are classified using a threetier system (Table 2 ) into low-, intermediate-
, and high-grade lesions based on the degree of nuclear pleomorphism. Nuclear pleomorphism 
represents one of just three components to be evaluated in the grading system of invasive breast 
carcinomas, the others being the number of mitoses and architectural growth pattern [ 32 ]. 
Histological grade (Table 2 ) holds a universally acknowledged robust prognostic value [ 32 ]; 
however, regrettably intra- and inter-pathologist agreement on grading in breast cancer is reported 
between poor and moderate [ 33 , 34 ]. Indeed, the interobserver agreement ranges between 50 
and 85 %, and about 40–50 % of breast cancers are diagnosed as grade 2 cancers [ 32 , 33 ]. 
Table 2 Schematic representation of how histological grade is performed in breast cancer 
diagnostic pathology 
 
Growth 
pattern 
Mitotic  count* 
(applied  to 
HPF diameter 
f )
Nuclear pleomorphism 
>75% of 
tubule 
formation 
 
SCORE 1 
1-4 mitoses 
 
SCORE 1 
Small and 
roundish  nuclei 
with uniform 
chromatin 
SCORE 1  
10-75% of 
tubule 
formation 
 
SCORE 2 
5-11 mitoses 
 
SCORE 2 
Variable  shape and 
size, vescicolous 
chromatin, nucleoli 
present 
SCORE 2  
<10% of 
tubule 
formation 
 
SCORE 3 
>=12  
mitoses 
 
SCORE 3 
High variability  in 
shape and size, 
prominent nucleoli 
SCORE 3 
 
TOTAL SCORE 
 
Score 3, 4, 5: G1 
Score 6, 7: G2 
Score 8, 9: G3 
Three parameters are assessed: evaluation of tubule formation, number of mitosis, and nuclear pleomorphism (the latter 
corresponding to nuclear grade) Scores attributed to single parameters are summed up, and the fi nal score labels the 
lesion as G1 (low grade), G2 (intermediate grade), or G3 (high grade) * Mitotic count depends on the diameter of the 
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microscopic field of the microscope used to analyze the tissue specimen, in the figure we reported values orresponding 
to 0.46 mm 
 
With respect to nuclear grade, the seminal work by Elston and Ellis 32 grades nuclear 
pleomorphism by using three score values. These score values are given by comparing tumor 
nuclei with nuclei of normal breast, and at least four features are considered: size, shape, 
uniformity of nuclear chromatin, and nucleoli. Score 1 nuclei are little larger but very similar to 
normal cell nuclei, while score 3 nuclei show marked variation in size and a “bizarre” morphology. 
Yet, as noted above with PTC, light microscopy appreciation of foldings and indentations of the 
nuclear membrane is rough and indirect, being based on the staining of membrane-bound 
chromatin. Based on these premises it is not surprising that systematic differences between 
pathologists in scoring nuclear pleomorphism in breast cancer potentially contribute to differences 
in allocating cases to the correct grade, and the observed discrepancies confirm the need for 
improved nuclear grading criteria 35, 36 . 
Despite their considerable biological interest, the intranuclear tubular extensions of the NE have 
not gained much attention in pathology. We have therefore endeavoured to investigate whether 
direct observation of the NE could provide a more objective and direct appreciation of nuclear 
pleomorphism of breast cancer cells with the fi nal aim to ameliorate definition of prognosis in 
breast cancer diagnostic pathology. 
First, we have carried out a project in which various cell lines (primary cultures of normal mammary 
epithelium and established breast cancer cell lines) in addition to isolated cells and tissue sections 
from primary human breast cancer of different grades and stages were examined. Finally, the 
degree of pleomorphism of the NE was extended to other pathological parameters (histological 
grade, number of metastatic lymph nodes, vascular invasion, staging) in a series of 273 breast 
cancers. 
Results with in vitro-immortalized cultures showed that nuclei of “normal” breast epithelium when 
put into 2D cultures displayed a uniformly smooth silhouette , while lamin B and emerin patterns in 
most breast cancer cell lines resulted to build up, upon 3D reconstruction, a complex scaffold of 
intranuclear tubular structures (Fig. 6 ). As for tumor cells in human surgical samples, we showed 
that high nuclear pleomorphism, as defined by staining of the NE proteins emerin and lamin (Fig. 3 
), may potentially recognize within the histologically low-grade cancer group (G1) and in tumors 
with low proliferation activity, those more prone to metastasize 37. 
Basically, from a practical standpoint, decoration/staining of the NE may be regarded as a novel 
diagnostic and prognostic parameter that may complement information obtained by conventional 
cytohistological techniques, and it can be postulated that fi ne detection of the nuclear shape and 
pleomorphism of the NE represents a novel parameter of interest in pathological grading, holding 
also a potential impact for planning therapy in breast cancer. Although the significance of this 
complex scaffold of intranuclear tubular structures is presently unknown it can be hypothesized 
that irregularities and intranuclear tubules might be involved in or reactive to defects in the nuclear-
cytoplasmic transport, reportedly a feature typical of cancer cells 38. 
As an additional remark, we have also investigated the possibility to visualize the spatial 
organization of gene signals with respect to the NE. This can be achieved by coupling 
immunofluorescence for lamins (or other NE proteins) and FISH for target genes. In particular, for 
breast cancer we have investigated HER2 gene amplification in BT-474 breast carcinoma cells 
(Fig. 4 ). HER2 gene amplifi cation is found in about 15–20 % of all breast carcinomas and 
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represents the main mechanism driving HER2 activation in breast cancer, which has a negative 
prognostic impact 33, 39. Proper documentation of the presence of HER2 gene amplification 
represents the crucial step to deliver a specific target therapy in breast carcinoma patients (the 
humanized antibody trastuzumab, i.e., Herceptin R ) 33. This is performed routinely by using an in 
situ technique, i.e.,FISH, with specific probes directed against the target gene, on sections of 
human tissue samples. Usually a dual-color probe (one for the gene, the other for the centromere 
of the chromosome 17 (CEP17), the chromosome where HER2 maps to) is employed, and results 
can be scored either based on HER2 /CEP17 ratio ( HER2/ CEP17≥2= amplification ) or on the 
basis of the absolute numbers of the HER2 gene (amplification whenever HER2 > 6) 39, 40 . For the 
sake of etection of amplification, only numerical count of signals is performed and no attention is 
currently paid to the spatial organization of signals. 
With our immune-FISH followed by 3D reconstruction we showed in HER2-amplifi ed breast cancer 
cells a range of patterns in the spatial distribution of gene signals (both single and clustered) with 
respect to the NE, some being anchored to the NE and others haphazardly spaced within the 
nucleus. Implications of the relationship between amplified regions of the genome and anchorage 
to the NE are unknown at present, but it is generally thought that interactions demonstrated 
between NE proteins and epigenetic heterochromatin marks would correlate peripheral localization 
with silencing. Nonetheless, further experimental studies would be warranted to properly 
investigate the implications in terms of activation or inactivation of genes. Indeed, the spatial 
localization of chromatin within the mammalian nucleus has been shown to be important for 
several genomic processes 41, including transcription 42, RNA processing 43, as well as DNA repair 
and recombination 44. In addition, studies based on 3D-immuno-FISH suggest a key function for 
the inner nuclear membrane–lamina compartment in transcriptional silencing of large segments of 
the genome 41. Finally, very recently it has been demonstrated that the yeast nuclear pore complex 
protein Nup170p interacts with regions of the genome that contain ribosomal protein and subtle 
omeric genes, where it functions as a repressor of transcription 45. These results suggest that 
nuclear pore proteins areactive participants in silencing and the formation of peripheral 
heterochromatin 45. 
 
Conclusions 
Variation in both nuclear shape and size (“pleomorphism”), coupled with changes in chromatin 
amount and distribution, remains the basic microscopy criteria for a cytologic diagnosis of cancer. 
The biological determinants of nuclear shape irregularities are not clarified. It has been suggested 
that alterations in nuclear shape might be related to genetic imbalances in cancer 46, and Fischer 17 
gave experimental evidence using in vitro models of PTC that induced gene mutations are 
associated with the structural features typical of this type of thyroid carcinoma that involve 
rearrangement of the NE and chromatin distribution 16, 17,47. On the other hand, some diseases 
characterized by genetically determined abnormalities in lamin proteins 48, 49 suggest that 
irregularities in nuclear shape are due to the abnormal farnesylation of lamin proteins, perhaps 
through interaction of the farnesylated lamins with the phospholipid bilayer 50. This raises the 
possibility that both genetic and posttranslational events might be involved in the origin of nuclear 
shape abnormalities. 
Indeed, small GTPases appear to represent a candidate for playing a central role in this process, 
since they are important in the nuclear envelope assembly 51 and are notoriously a key player in 
oncogenesis 52 , 53. Moreover, recent evidence has been presented 54 suggesting that prenylation 
of small GTPases is impaired in cancer cells. 
Other reviews focus on possible mechanisms to generate nuclear shape abnormalities, but here 
we focus on using these diagnostically. Standard H&E staining cannot adequately distinguish fi ne 
abnormalities of the nuclear shape, as it is indirectly based on the distribution of DNA as revealed 
by the affinity for basic dyes. 
A more objective definition of the shape of the nucleus can be provided by decoration/staining of 
the NE, followed by image capture and 3D reconstruction. We applied this approach to two areas 
of tumor pathology: thyroid and breast cancer. In the papillary type of thyroid cancer, most nuclei 
show a variation in shape so typical as to be paradigmatic and diagnostic, while in breast cancer 
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nuclear irregularities vary according to the subtype and the aggressiveness of cancer. For instance 
it is minimal in tubular carcinoma while marked in grade 3 cancers. 
The technical approach presented here proved feasible on both isolated cells and tissue sections 
and ultimately provides a reproducible approach of diagnostic and clinical interest. 
The pathological diagnosis of PTC is usually straightforward since the majority of cases of PTC are 
easy to diagnose on routine-stained preparations, with overt irregularities, such as grooves, 
pseudo-inclusions, and ground-glass appearance. 
Although these nuclear changes help to defi ne PTC, these features are only diagnostic when 
widespread and in combination. However, in some cases both in histology and cytology diagnosis 
of PTC can be challenging, and the classical microscope observation of PTC nuclei (based on 
nucleic acid staining with basic dyes, such as hematoxylin) is clearly insuffi cient to appreciate the 
complete spectrum of PTC nuclear irregularities. 
By tracing in immunofluorescence and immunoperoxidase proteins of the NE (e.g., lamins, 
emerin), it is possible to obtain a clear, evident, and direct representation of nuclear shape, thus 
highlighting those microscopical features barely visible with H&E. 
When shifting the attention from the “content” (chromatin) to the “container” (nuclear membrane), 
confocal microscopy and 3D reconstructions provided us models of nuclear structure in PTC cells, 
and emerin immunostaining on cytological and histological samples proved a feasible tool to 
improve diagnosis in “difficult” PTC cases. 
In breast cancer, the presence of an extensive network of invaginated projections of the NE inside 
the nucleus, as revealed by tagging lamin B and emerin in immunofluorescence preparations, 
opens prospects of biological and diagnostic interest. 
 
Intranuclear tubules are an interesting and intriguing phenomenon, possibly involved in or reactive 
to defects in the nuclear-cytoplasmic transport, reportedly a feature typical of cancer cells. In 
addition, this scaffold might also be a drug target since Lee et al. 55 already demonstrated a 
selective binding of doxorubicin to intranuclear tubules. Moreover, the combined 3D detection of 
the spatial distribution of genes and intranuclear invaginations, as exemplified in the present study, 
might provide a novel interpretation on active versus inactive genes. Indeed, other studies 
based on 3D-immuno-FISH seem to suggest the inner nuclear membrane–lamina compartment as 
a key player in transcriptional silencing of large segments of the genome 41. 
Finally, we gave evidence that immunofluorescence decoration/staining of the NE provides a 
reproducible and objective evaluation of nuclear shape irregularities associated with pleomorphism 
and provides prognostic information to parallel and enhance that provided by routine histological 
procedures. 
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